Read more

March 13, 2024
1 min read
Save

Baseline, post-acute kidney function key in evaluating patients with AKI needing dialysis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • All-cause mortality was 28.3% during a mean of 1.2 years follow-up in the study cohort.
  • Incidence rate of major adverse cardiac events was 11.1%.

Measuring baseline and post-acute kidney function is key in evaluating the risk of adverse outcomes in patients requiring dialysis, according to a nationwide cohort study.

“Unlike AKI and [chronic kidney disease] ... [acute kidney disease] AKD is a relatively novel entity, and the association between the severity of AKD and outcomes is currently unclear,” Heng-Chih Pan, MD, of the College of Medicine at National Taiwan University in Taipei, and colleagues wrote. There is a need to monitor patients with kidney disease to “determine when kidney function status may play a role in the assessment of adverse outcomes.”

Pan_Graphic
Data derived from Pan HC, et al. JAMA Netw Open. 2024;doi:10.1001/jamanetworkopen.2024.0351.

Researchers studied 6,703 adults (mean age; 68 years) who had AKI requiring dialysis (AKI-D) with post-AKD kidney function follow-up and AKD stage data. The population-based study used data from health care settings in Taiwan to find the impact of baseline kidney function, AKD severity and kidney function post-AKD on results.

All-cause mortality and incident major adverse cardiac events (MACEs) were main outcomes, followed by permanent dialysis and readmission.

Baseline and post-AKD kidney function were significant independent factors “associated with the long-term prognosis of patients with AKI-D,” the researchers wrote. Each was linked with all-cause mortality, MACEs, end-stage kidney disease and readmission. “Concerted efforts to understand the transition from post-AKD to [CKD] are crucial,” they wrote.

Researchers found an all-cause mortality rate of 28.3% at mean of 1.2 years follow-up. Incidence rates of MACEs and ESKD were 11.1% and 16.7%, respectively. Worse post-AKD function correlated with an increased risk of adverse outcomes, according to the results. AKD severity was not associated with adverse outcomes.

“Stratifying patients with AKI-D by post-AKD and baseline kidney function can improve prognostic prediction along with objective information in clinical practice,” Pan and colleagues wrote. “Coordination of care to reduce post-AKD CKD transition is important.”